In January, the UK Government announced a new partnership to boost research into vaccines for cancer. From as early as September, UK patients will be among the first in the world to participate in trials of the new mRNA cancer “vaccines.”
The Department of Health and Social Care (DHSC) [6 January 2023] announced a formal collaboration with BioNTech SE to accelerate research into using its vaccine technology against cancer, and test personalised mRNA therapies on NHS patients, which some experts are calling “revolutionary.”
New ‘Revolutionary’ Cancer Vaccine Research Hub Announced, Medscape UK, 6 January 2023
A memorandum of understanding was signed by the Health Secretary, Steve Barclay, to explore personalized mRNA vaccines with the German company BioNTech which co-developed the leading covid-19 “vaccine” with Pfizer.
BioNTech said that the collaboration focused on “three strategic pillars”: cancer immunotherapies based on mRNA or other drug classes, infectious disease vaccines, and expansion of BioNTech’s footprint in the UK as “one of the company’s key markets”.
This unique collaboration promises to deliver 10,000 personalized therapies to NHS cancer patients by 2030 through the creation of a “cancer vaccine launch pad.” A new center will open in Cambridge to coordinate both the science and clinical strategy.
Using mRNA to encode useful proteins in vivo has been around in the lab for years, Medscape reported. But the covid vaccine program driven by BioNTech and Moderna has shown how quick to produce and how potent mRNA-based products can be.
The second key factor driving this newfound optimism in immuno-oncology is the partial success of the checkpoint inhibitors pembrolizumab, nivolumab, atezolizumab, and ipilimumab in a wide range of cancers.
Medscape noted a third driver of interest in mRNA cancer “vaccines” to be the speed at which DNA sequence data can be obtained from clinical samples. What used to take weeks can be achieved in seconds and large datasets are compared instantly by sophisticated software. So, the mutations in an individual tumor can be mapped and the relevant mRNA constructs made and inserted into a suitable vector within days. Medscape’s article continued:
This technology will create a new way of working for big pharma. A whole new service culture will be needed – pathology services will need to curate and supply fresh tissue; hospital pharmacies will need to engage with new organisations to deliver bespoke vaccines and provide them to oncologists ready for injection. And there are many variables in terms of dose, timing, the use of checkpoint inhibitors to take the brakes off the immune response and, of course, the addition of more conventional radiotherapy and chemotherapy.
Will mRNA Cancer Vaccines Live Up to Their Promise? Medscape, 10 February 2023
BioNTech developed the known to be harmful covid injection which was then marketed by Pfizer. One of the effects of Pfizer-BioNTech’s covid injections is cancer. After ineffective and unsafe covid mRNA injections administered without informed consent, do you trust BioNTech and/or the system that promotes and supports its products to design and administer a “safe and effective” personalized mRNA injection for you?
What Will the Future Look Like?
Medscape’s article provided a prediction of what the future of cancer patients could look like. Doctors should be aware that their role is likely to become redundant and, in the future, they will merely serve as vaccinators.
The cancer patient of 2040 will have minimally invasive robotic surgery to remove their primary cancer and a full staging process by sophisticated imaging. Radiotherapy using artificial intelligence to optimize the treatment plan will be given if there is a significant risk of local recurrence.
Molecular analysis of the removed cancer will determine the risk of systemic spread. If high, a program of chemo-immunotherapy will be triggered. The individual pattern of antigen expression on the tumor will be evaluated by robotic analysis and an AI-generated series of mRNA sequences encoding the relevant epitopes generated. These will be taken from the curated repository and delivered in a suitable form for injection by the oncologist.
The service providers will be different from today. There will be local collectors of tissue and central laboratories run by today’s big pharma. Robots will identify and insert the appropriate sequences into vectors ready for injection into individuals. Maybe they will already be synthesized and stored in vials rather like the jars in an old-fashioned chemist’s shop. Everything will be based on a recurrence risk assessment. The oncologist will be provided with a printout of the sequences for injection and a week afterward a blood sample will be taken to verify a successful immune response to the translated epitopes.
You can read Medscape’s full article ‘Will mRNA Cancer Vaccines Live Up to Their Promise?’ by Karol Sikora HERE.
In November 2021 we published an article that noted Sikora was one of the experts who refused to acknowledge that covid injections could be contributing to excess deaths. Instead, Sikora blamed a “backlog” in reporting and a “lack of access to health care” as the cause of deaths.
Karol Sikora is a Professor of Medicine at The University of Buckingham and an adviser to the World Health Organisation. He currently directs a cancer drug donation program in Africa. He is also a member of the Oncology Scientific Advisory Board at biopharmaceutical company Cyclacel Limited and serves as an oncology consultant for AstraZeneca.
Article cross-posted from The Daily Exposé.
Bypass Big Tech Censors
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.